NexImmune (NASDAQ: NEXI) Says FDA Granted IND Clearance for NEXI-003 and Treatment of HPV-Based Cancers
NexImmune, Inc. (NASDAQ: NEXI) is engaged as a clinical-stage biotechnology company, which is focused on developing new, novel immunotherapy treatments ...